Thomas R. Clark Sentencing Motion Denied

The Delaware Superior Court denied Thomas R. Clark's motion for correction of an illegal sentence. Clark pleaded guilty to firearm offenses and was sentenced on October 1, 2024. The court found his motion lacked merit, as his sentence was negotiated and agreed upon as part of a plea agreement.

Executive Order Banning Insider Betting by State Officials

California Governor Gavin Newsom issued an executive order strengthening bans on state officials using non-public information for personal profit, specifically targeting prediction markets. The order extends prohibitions to appointees and their associates, aiming to prevent corruption fueled by insider knowledge, particularly in light of federal examples.

ACME UNITED CORPORATION Class II Recall: BZK Antiseptic Towelettes

The FDA has initiated a Class II recall for ACME UNITED CORPORATION's BZK Antiseptic Towelettes due to CGMP deviations. The recall affects product distributed nationwide within the United States.

ACME UNITED CORPORATION Class II Drug Recall

The FDA has issued a Class II recall for ACME UNITED CORPORATION's Hand Sanitizing Wipes due to CGMP deviations. The recall, identified as D-0373-2026, is ongoing and affects product distributed nationwide in the United States.

HTO Nevada Inc. Recalls Lidocaine Cream Due to Stability Data

HTO Nevada Inc. is recalling its MAXIMUM, ZONE 1, 4% Lidocaine Cream (NDC 80069-014) nationwide due to stability data not supporting the expiry date. This is a Class II recall, indicating that use of or exposure to the product may cause temporary or medically reversible adverse health consequences.

ACME UNITED CORPORATION Class II Drug Recall D-0358-2026

The FDA has initiated a Class II drug recall (D-0358-2026) for ACME UNITED CORPORATION's First Aid Only BZK Antiseptic Towelettes due to Current Good Manufacturing Practice (CGMP) deviations. The recall affects a nationwide distribution within the United States.

ACME UNITED CORPORATION Class II Drug Recall D-0369-2026

The FDA has initiated a Class II drug recall (D-0369-2026) for Dynarex Obstetrical Towelettes Cleanser manufactured by ACME UNITED CORPORATION due to CGMP deviations. The recall affects product distributed nationwide within the United States.

New Life Pharma LLC Class II Drug Recall for Tirzepatide Inj

The FDA has initiated a Class II drug recall for New Life Pharma LLC's Tirzepatide Inj (NDC 84223-002-03) due to a lack of assurance of sterility. The recall affects product distributed in Ohio.

New Life Pharma LLC Class II Drug Recall - Semaglutide Inj

The FDA has issued a Class II drug recall for Semaglutide Inj manufactured by New Life Pharma LLC due to a lack of assurance of sterility. The recall affects product distributed in Ohio.

ACME UNITED CORPORATION Class II Drug Recall D-0375-2026

The FDA has initiated a Class II drug recall for ACME UNITED CORPORATION's Dynarex BZK Antiseptic Towelettes due to CGMP deviations. The recall affects product distributed nationwide in the United States.